Lung cancer Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 and over 2. Able to provide written informed consent to participate in the study 3. English speakers 4. Body weight within minimum and maximum scanner requirements of 50-100 kg 5. Diagnosed with non-small cell lung cancer by the clinical team 6. Planned to receive radical OR high dose palliative radiotherapy (+/- adjuvant chemotherapy or surgery)
Exclusion criteria
Exclusion criteria: 1. Patients below the age of 18 years 2. Patients who are not able or decline to give informed consent to participate in the study 3. Non-English speakers 4. Body habitus incompatible with positioning within the MRI scanner sensor used for 19F-MRI (approximately equivalent to a body circumference > 120cm at chest height, and body mass index > 35 kg/m²) 5. Pregnant or breastfeeding 6. MRI contraindications: incompatible implanted medical device (e.g. cardiac pacemaker), or metallic implants incompatible with MRI 7. Claustrophobia incompatible with MRI
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of ventilated lung volume (%VV) measured using fluorine MRI study data to characterise the extent of lung ventilation defects in the lungs of lung cancer patients before radiotherapy (single scan, baseline) at one time point | — |
Secondary
| Measure | Time frame |
|---|---|
| Regional tracer gas wash-in and wash-out rates measured using the fluorine MRI scan, and clinical lung function measured using spirometry at baseline | — |
Countries
United Kingdom